German Aortic Center Hamburg, Department of Vascular Medicine, University Heart and Vascular Center, Hamburg, Germany.
German Aortic Center Hamburg, Department of Vascular Medicine, University Heart and Vascular Center, Hamburg, Germany; Departments of Vascular Surgery, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
J Vasc Surg. 2021 Dec;74(6):1817-1824. doi: 10.1016/j.jvs.2021.05.041. Epub 2021 Jun 23.
The t-Branch, a standardized off-the-shelf multi-branched stent graft has been used for the treatment of elective and urgent cases in aortic disease. The aim of this study was to assess the early outcomes in terms of technical success, mortality, and morbidity in >500 patients being treated with the t-Branch device.
A two-center retrospective observational study was undertaken including patients treated using the t-Branch (Cook Medical, Bloomington, IN) in elective or urgent settings for complex abdominal aortic aneurysm and thoraco-abdominal aortic aneurysm between 2014 and 2019 (early experience 2014-2016; late experience 2017-2019). Primary endpoints were technical success and early (30-day) mortality, and secondary endpoints were early morbidity, endoleak, and target vessel patency rates. Multivariable regression models were used to determine the independent association of risk factors with (1) mortality and (2) spinal cord ischemia.
A total of 542 patients (mean age, 70.5 ± 8.5 years; 388 men [72%]; mean aneurysm diameter, 7.5 ± 2.5 cm) were included (63% elective; 90% thoraco-abdominal aortic aneurysm). The technical success rate was 97% (526/542) (elective, 96.7% [328/339] vs urgent, 97.6% [208/213]). The total 30-day mortality rate was 12.3% (8.5% in elective, 15% in symptomatic, and 30% in contained rupture). After multivariate regression analysis, the mortality rate was associated with older age (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.03-1.11; P < .001) and with lower baseline glomerular filtration rate (OR, 0.98; 95% CI, 0.98-0.99; P < .001). In elective cases, the mortality rate was associated with a history of coronary artery disease (OR, 0.26; 95% CI, 0.09-0.73; P < .011) and higher body mass index (OR, 0.87; 95% CI, 0.77-0.98; P < .027). In urgent cases, the mortality rate was associated with older age, (OR, 1.07; 95% CI, 1.02-1.13; P < .010) and lower baseline glomerular filtration rate (OR, 0.97; 95% CI, 0.95-0.99; P < .001). The spinal cord ischemia rate was 10.5% (6.5% temporary, 4% permanent) and was associated with the early study period (OR, 2.01; 95% CI, 1.03-3.89; P < .038). The renal impairment rate was 13%, the stroke rate was 2.5%, and the myocardial infarction rate was 1.8%, whereas the access complications rate was 7.7%. On early computed tomography angiography, the primary patency rate for the right renal artery was 99.6%, for the left renal artery was 100%, for the superior mesenteric artery was 99.4%, and for the coeliac trunk was 99.8%. The endoleak I and III rates were 2.7% (15/542) and 2.7% (15/542), respectively.
Elective and urgent use of the t-Branch multi-branched off-the shelf stent graft showed high technical success and early target vessel patency rates. Early mortality and morbidity rates were acceptable.
t-Branch 是一种标准化的分支型支架移植物,已被用于治疗主动脉疾病的择期和紧急病例。本研究的目的是评估 500 多例使用 t-Branch 装置治疗的患者的早期技术成功率、死亡率和发病率,以评估其疗效。
本研究为回顾性、多中心研究,纳入了 2014 年至 2019 年间在择期或紧急情况下使用 t-Branch(库克医疗公司,印第安纳州布卢明顿)治疗复杂腹主动脉瘤和胸腹主动脉瘤的患者。主要终点为技术成功率和 30 天内死亡率,次要终点为早期发病率、内漏和靶血管通畅率。采用多变量回归模型确定危险因素与(1)死亡率和(2)脊髓缺血的独立相关性。
共纳入 542 例患者(平均年龄 70.5±8.5 岁;388 例男性[72%];平均瘤径 7.5±2.5cm)(63%为择期手术,90%为胸腹主动脉瘤)。技术成功率为 97%(526/542)(择期手术成功率为 96.7%[328/339],紧急手术成功率为 97.6%[208/213])。30 天内总死亡率为 12.3%(择期手术 8.5%,症状性 15%,破裂包块内 30%)。多变量回归分析后,死亡率与年龄较大(比值比[OR],1.07;95%置信区间[CI],1.03-1.11;P<0.001)和基线肾小球滤过率较低(OR,0.98;95%CI,0.98-0.99;P<0.001)相关。在择期手术中,死亡率与冠心病病史(OR,0.26;95%CI,0.09-0.73;P<0.011)和较高的体重指数(OR,0.87;95%CI,0.77-0.98;P<0.027)相关。在紧急手术中,死亡率与年龄较大(OR,1.07;95%CI,1.02-1.13;P<0.010)和较低的基线肾小球滤过率(OR,0.97;95%CI,0.95-0.99;P<0.001)相关。脊髓缺血发生率为 10.5%(6.5%为暂时性,4%为永久性),与早期研究期间有关(OR,2.01;95%CI,1.03-3.89;P<0.038)。肾功能不全发生率为 13%,脑卒中发生率为 2.5%,心肌梗死发生率为 1.8%,而血管入路并发症发生率为 7.7%。在早期 CT 血管造影中,右肾动脉一级通畅率为 99.6%,左肾动脉为 100%,肠系膜上动脉为 99.4%,腹腔干为 99.8%。内漏 I 型和 III 型发生率分别为 2.7%(15/542)和 2.7%(15/542)。
t-Branch 多分支支架移植物的择期和紧急使用显示出较高的技术成功率和早期靶血管通畅率。早期死亡率和发病率是可以接受的。